Jane Barlow, Russell Teagarden, Mark Trusheim

Jane Barlow is Senior Advisor to FoCUS Project (Jane Barlow & Associates, LLC); Russell Teagarden is Research Affiliate and Senior Advisor to FoCUS Project (Massachusetts Institute of Technology); and Mark Trusheim is Strategic Director, NEWDIGS and Visiting Scientist, Sloan School of Management, Massachusetts Institute of Technology.


Precision Financing of Durable, Potentially Curative Therapies

While gene therapies and cellular treatments are a boon for patients, they can be a financial bane for payers. Jane Barlow, Russell Teagarden, and Mark Trusheim outline alternative financing approaches, customizable for each payer’s needs and for each therapy’s characteristics.